Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 601–700 of 978
Pinchevsky, Y., Shukla, V., Butkow, N., Chirwa, T. F., & Raal, F. J. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s119965 · Cited by 9
Electronic clinical reminder and quality of primary diabetes care
Wu, S. S., Chan, K. S., Bae, J., & Ford, E. W. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.08.007 · Cited by 9
Langford, A. T., Wang, B., Orzeck-Byrnes, N. A., Aidasani, S. R., Hu, L., Applegate, M., Moloney, D. N., Sevick, M. A., Rogers, E., & Levy, N. (2018) · Patient Education and Counseling · doi:10.1016/j.pec.2018.09.016 · Cited by 9
Routh, B., Hurt, T. R., Winham, D. M., & Lanningham‐Foster, L. (2019) · Global Qualitative Nursing Research · doi:10.1177/2333393619852343 · Cited by 13
“In alignment with the SCT, because T2DM nutrition care behaviors were shaped by complex factors and experiences over time (Ali et al., 2013), varying familial influences could lead to differences in whether or not risky T2DM behaviors were transmitted across generations.”
Katsiki, N., Ofori‐Asenso, R., Ferrannini, E., & Mazidi, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13989 · Cited by 10
“>7%).(1) This pattern can be attributed to polypharmacy, fear of side effects, cost and clinical (therapeutic) inertia from both patients and physicians.”
BackgroundInfluentialQuality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
Davari, M., Bayazidi, Y., Kebriaeezadeh, A., Esteghamati, A., Bandarian, F., Kashi, Z., Bahar, A., & Yousefi, S. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01034-2 · Cited by 10
“Many studies have shown that insulins are more effective in managing T2DM than oral medications, particularly in patients with HbA1c above 7% [29, 30, 31, 32].”
BackgroundAbdel‐Rahman, N., Calderon‐Margalit, R., Cohen, A. D., Elran, E., Golan‐Cohen, A., Krieger, M., Paltiel, O., Valinsky, L. J., Ben‐Yehuda, A., & Manor, O. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025603 · Cited by 10
Hu, S., Lin, C., Cai, X., Li, Z., Lv, F., Yang, W., & Ji, L. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101868 · Cited by 11
Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
Jain, R. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0262-9 · Cited by 9
Shivashankar, R., Bhalla, S., Kondal, D., Ali, M. K., Prabhakaran, D., Narayan, K. M. V., & Tandon, N. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.180000 · Cited by 10
Self-citationTrends in the Care and Outcomes of Medicare Beneficiaries with Type 2 Diabetes, 2002–2011
Hyland, K. A., Greiner, M. A., Qualls, L. G., Califf, R. M., Hernandez, A. F., & Curtis, L. H. (2016) · Endocrine Practice · doi:10.4158/ep15807.or · Cited by 11
Merton, K., Davies, M. J., Vijapurkar, U., Inman, D., & Meininger, G. E. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1391759 · Cited by 10
Kim, K., Unni, S. K., McAdam‐Marx, C., Thomas, S. M., Sterling, K. L., Olsen, C. J., Johnstone, B. M., Mitchell, M., & Brixner, D. I. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.3.314 · Cited by 11
Jayanna, M. B., & Robinson, J. G. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13701 · Cited by 11
Discovery of LY3325656: A GPR142 agonist suitable for clinical testing in human
Liu, L. Z., Ma, T., Zhou, J., Hu, Z. L., Zhang, X. J., Zhang, H. Z., Mi, Z., Liu, J., Li, L., Jiang, Y., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126857 · Cited by 9
Diabetes Report Card — Time for a Winning Streak
McMahon, G. T., & Dluhy, R. G. (2013) · New England Journal of Medicine · doi:10.1056/nejme1302610 · Cited by 9
Diabetes and periodontal therapy
Pihlstrom, B. L., & Buse, J. B. (2014) · The Journal of the American Dental Association · doi:10.14219/jada.2014.112 · Cited by 10
Siddiquea, B. N., Magliano, D. J., Chowdhury, H. A., Chowdhury, M. R. K., Afroz, A., Shah, S. S., & Billah, B. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1695235 · Cited by 13
Bell, K. F., Katz, A., & Sheehan, J. (2016) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s108586 · Cited by 9
“In an analysis of data from the National Health and Nutrition Examination Survey (2007–2010, N=1,444), approximately half of patients with T2D did not achieve A 1C , BP, or LDL-C goals.(8) The purpose of the Table 1 Current US quality measures for diabetes with association recommendations”
Neff, L. M., Broder, M. S., Beenhouwer, D. O., Chang, E., Papoyan, E., & Wang, Z. W. (2017) · Clinical Obesity · doi:10.1111/cob.12213 · Cited by 10
Amadid, H., Rønn, P. F., Dunbar, M. B., Knudsen, J. S., Carstensen, B., Persson, F., & Jørgensen, M. E. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14478 · Cited by 8
White, A., Buschur, E., Harris, C., Pennell, M. L., Soliman, A., Wyne, K. L., & Dungan, K. M. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s327158 · Cited by 8
“Despite increasing costs and disproportionate healthcare utilization, only about half of patients successfully achieve glycemic control, indicating unmet needs for diabetes care and self-management support.(3,4) In addition, only 64% of patients achieve individualized Healthcare Effectiveness Data and Information Set…”
BackgroundTateyama, Y., Shimamoto, T., Uematsu, M. K., Taniguchi, S., Nishioka, N., Yamamoto, K., Okada, H., Takahashi, Y., Nakayama, T., & Iwami, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1195167 · Cited by 10
“To prevent the onset and worsening of DM, comprehensive intervention that includes tight control of blood glucose levels; control of obesity, blood pressure, and lipid levels; smoking cessation; early detection of nephropathy; and nutritional guidance is required (7, 8).”
BackgroundMethodPredictors of lack of glycemic control in persons with type 2 diabetes
Louie, J. Z., Shiffman, D., Rowland, C. M., Kenyon, N. S., Bernal‐Mizrachi, E., McPhaul, M. J., & Garg, R. (2024) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-023-00160-7 · Cited by 8
“These numbers have remained unchanged over the last two decades, despite pharmaceutical and technological advances in the field [4, 5].”
Vouillarmet, J., Marsot, C., Maucort‐Boulch, D., Riche, B., Helfre, M., & Grangé, C. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9059761 · Cited by 8
Harding, J. L., Morton, J. I., Shaw, J. E., Patzer, R. E., McDonald, S. P., & Magliano, D. J. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab315 · Cited by 9
Medical Practice Variations in Diabetes Mellitus
Gamble, J., & Butalia, S. (2016) · Springer eBooks · doi:10.1007/978-1-4899-7603-1_85 · Cited by 10
Lynch, C. P., Williams, J. L. S., Reid, J., Joseph, R., Keith, B. A., & Egede, L. E. (2014) · PubMed · Cited by 9
Garzón, G., Gil, Á., Herrero, A. M., Jiménez, F., Cerezo, M. J. G., & Domínguez, C. J. (2015) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2015.07.010 · Cited by 15
Do we need new treatments for type 2 diabetes?
Peralta, F. G., & Padín, C. A. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.06.002 · Cited by 9
Lee, J. D., Saravanan, P., Varadhan, L., Morrissey, J. R., & Patel, V. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-467 · Cited by 9
“Disappointingly, there remains frequent sub-optimal performance of diabetes care processes and control of cardiovascular risk factors [3,4].”
BackgroundImam, S. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00003-x · Cited by 8
Brugos‐Larumbe, A., Herce, P. A., Guillén‐Grima, F., Garjón, J., Resano, F. J. B., Beloqui, M. A., Pérez-Ciordia, I., Fernández-Navascués, A. M., Lerena-Rivas, M. J., Reyero, J. B., et al. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.06.008 · Cited by 8
AlShareef, S. M., AlKhathlan, M. A., Alwabel, A. A., Al-Bawardi, A. A., Alqarni, A. H., Almuryidi, A. S., Altuwaim, I. N., Alhabib, M. K., Almuzaini, O. A., & Alqahtani, T. S. (2018) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_126_17 · Cited by 8
Effect of reducing medication regimen complexity on glycaemic control in patients with diabetes
Abdelaziz, T. S., & Sadek, K. (2018) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2018-0029 · Cited by 11
Liu, C.-L., Lin, M., Hwang, S., Liu, C., Lee, H., & Wu, M. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.10.014 · Cited by 9
Medication Adherence and Its Associated Factors in Laotians With Type 2 Diabetes Mellitus
Kang, Y., & Hur, Y. (2019) · Clinical Nursing Research · doi:10.1177/1054773819849349 · Cited by 8
“Specifically, individuals with DM should maintain the proper blood glucose level by adhering to a medication regimen and following a healthy lifestyle (Ali et al., 2013; Krapek et al., 2004; S. W. Lee, Lee, Tan, & Wong, 2016).”
BackgroundChiou, C.-C., Tsai, T., Lee, C., Lin, C.-J., Chung, W.-J., Hsuch, S.-K., Wu, P., & Cheng, C. (2019) · PubMed · doi:10.6515/acs.201905_35(3).20181122b · Cited by 13
Wang, J., Chen, H., Tang, F., & Sheu, W. H. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13485 · Cited by 9
Filho, W. E., Bonjorno, L. P., Franco, A. J. M., dos Santos, M. L. A., de Souza, E. M., & Marcon, S. S. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0173-1 · Cited by 8
Universidad Industrial de Santander. Bucaramanga, C., G, S. L. R., Parra, D. I., Universidad Industrial de Santander. Bucaramanga, C., Rodríguez, J. M. S., Universidad Industrial de Santander. Bucaramanga, C., Rojas, L. Z., & Universidad Industrial de Santander. Bucaramanga, C. (2017) · Salud UIS · doi:10.18273/revsal.v49n1-2017004 · Cited by 19
Wang, J., Hung, Y.-J., Lu, Y.-C., Tsai, C.-L., Yang, W., Lee, T.-I., Hsiao, Y.-C., & Sheu, W. H. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.002 · Cited by 9
Closing Gaps in Diabetes Care: From Evidence to Practice
Ba-Essa, E. M., Abdulrhman, S., Karkar, M., Alsehati, B., Alahmad, S., Aljobran, A., Aldijwi, A., & Alhawaj, A. H. (2018) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_86_17 · Cited by 12
“For example, in the United States, it has been found that 33%–49% of the adults with diabetes do not meet targets for glycemic, BP or cholesterol control, and only 14% meet the targets of all three measures as well as attain a nonsmoking status.[13] Therefore, the objective of the current study was to demonstrate that…”
BackgroundYokoyama, H., Araki, S., Kawai, K., Yamazaki, K., Tomonaga, O., Maeda, H., Ohtaki, M., Obata, H., Sone, H., Kabata, D., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110674 · Cited by 9
Liu, H., Wang, F., Xia, H., Pan, D., Yang, L., Wang, S., Zhao, F., & Sun, G. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.042 · Cited by 9
Sun, M., Lu, Z., Chen, W., Lv, S., Fu, N., Yang, Y., Wang, Y., Miao, M., Wu, S., & Zhang, J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119117 · Cited by 9
Cheng, L., Wang, X., Dang, K., Hu, J., Zhang, J., Xu, X., Pan, S., Qi, X., & Li, Y. (2025) · European Journal of Nutrition · doi:10.1007/s00394-024-03552-2 · Cited by 7
“…in patients with T2DM is essential for preventing and treating CVD. Controlling CVD risk factors such as blood pressure and blood lipids through diet and behavior has also been found to significantly reduce the risk of complications, disabil - ity, and death in individuals with T2DM [5, 7, 8].”
Schwartz, S. S., & Katz, A. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s65588 · Cited by 8
“Furthermore, despite a wide range of available treatment options, only ∼50% of patients with diabetes in the United States have glycated hemoglobin (A 1C ) ,7%.(9,10) Chronic uncontrolled hyperglycemia increases the risk of microvascular complications (nephropathy, retinopathy, and neuropathy), macrovascular complicat…”
Medical Home Characteristics and Quality of Diabetes Care in Safety Net Clinics
Gunter, K. E., Nocon, R. S., Gao, Y., Casalino, L. P., & Chin, M. H. (2016) · Journal of Community Health · doi:10.1007/s10900-016-0256-9 · Cited by 7
“It has been difficult nationally to provide high quality care that leads to ideal patient outcomes and primary care providers across diverse settings struggle to provide diabetes care that is consistent with current recommended guidelines [2, 4, 9, 30].”
Primary Prevention of Type 2 Diabetes: An Imperative for Developing Countries
Dagogo-Jack, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-41559-8_2 · Cited by 8
Down, S., Alzaid, A., Polonsky, W. H., Belton, A. B., Edelman, S. V., Gamerman, V., Nagel, F., Lee, J., Emmerson, J., & Capehorn, M. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.012 · Cited by 7
Cannon, A. J., Bargiota, Α., Billings, L. K., Hunt, B., Leiter, L. A., Malkin, S. J. P., Mocarski, M., Ranthe, M. F., Schiffman, A. B., & Doshi, A. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.19035 · Cited by 7
Diabetes Management in Community Health Centers: a Review of Policies and Programs
Kelley, A. T., Nocon, R. S., & O’Brien, M. J. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1289-0 · Cited by 9
Aleksić, S., Eisenberg, R. E., Tsomos, E., Anaraki, S. Z., Japp, E., Upadhyay, L., Mowrey, W. B., Akalin, E., & Zonszein, J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108221 · Cited by 7
Progress in reducing vascular complications of diabetes
Booth, G. L., & Zinman, B. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.90 · Cited by 7
Mendivil, C. O., Márquez-Rodríguez, E., Ángel, I. D., Paz, G. H. Y., Rodríguez, C., Almada, J., & Szyskowsky, O. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.928274 · Cited by 7
Chemical Composition, Fatty Acids Content and Glycemic Index of Two Different Types of Omani Halwa
Ali, A., Al-Zuhaibi, K. M., Waly, M. I., Al‐Alawi, A., Al-Sabahi, J. N., & Sankar, D. (2013) · Pakistan Journal of Nutrition · doi:10.3923/pjn.2013.753.760 · Cited by 9
“(Al-Khawaldeh et al., 2012; Ali et al., 2013).”
BackgroundMethodInfluentialDevelopment and assessment of a simple scoring system for the risk of developing diabetic foot
Tomita, M., Kabeya, Y., Okisugi, M., Kawasaki, M., Katsuki, T., Oikawa, Y., Shimada, A., & Atsumi, Y. (2014) · Diabetology International · doi:10.1007/s13340-014-0189-4 · Cited by 7
Control metabólico en pacientes diabéticos ambulatorios de un hospital general
Jasso-Huamán, L. E., Villena-Pacheco, A., & Linares, X. G. (2015) · Revista Médica Herediana · doi:10.20453/rmh.v26i3.2584 · Cited by 7
“A pesar de las recomendaciones clínicas basadas en la evidencia, hay múltiples estudios que indican que no se consigue un grado de control aceptable en una proporción importante de diabéticos (11-15).”
BackgroundHenry, R. R., Rosenstock, J., McCarthy, J. F., Carls, G. S., Alessi, T., Yee, J., & Baron, M. A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13133 · Cited by 7
The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use.
Tang, Y., Huang, X., Liu, J., Shankar, R. R., Ganz, M. L., & Rajpathak, S. N. (2017) · Europe PMC (PubMed Central) · Cited by 11
Diabetes and Long-Term Complications
Cagliero, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00051-2 · Cited by 11
Grady, M., Venugopal, U., Robert, K., Hurrell, G., & Schnell, O. (2019) · JMIR Human Factors · doi:10.2196/13847 · Cited by 9
“0% has been fairly constant from 2003 to 2010, remaining at just over 50% [1].”
BackgroundDiabetes and Humor: A Preliminary Investigation
Greene, D. S., King, N. D., & Coe, J. B. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0028 · Cited by 7
Sauder, K. A., Stafford, J. M., Ehrlich, S. R., Lawrence, J. M., Liese, A. D., Marcovina, S. M., Mottl, A. K., Pihoker, C., Saydah, S., SHAH, A. S., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2983 · Cited by 7
Self-citationBae, J. (2013) · Journal of Preventive Medicine & Public Health · doi:10.3961/jpmph.2013.46.5.249 · Cited by 7
“However, a report on the achievement of goals in diabetes care in the US from 1999 to 2010 demonstrated that although there were notable advancements in risk factor control and adherence to preventive practices, tobacco use in this vulnerable population remained considerable [9].”
BackgroundPulmonary Complications of Endocrine Diseases
Zimmerman, L. H. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00095-6 · Cited by 9
“Regarding preventive practices in patients with known diabetes, approximately 60% have obtained annual influenza vaccines, whereas just 49% have met goals of pneumococcal vaccination.(69) As for other pathogens, preexisting diabetes has been associated with a higher mortality in patients with severe acute respiratory…”
BackgroundManagement of Type 2 Diabetes Mellitus
Dungan, K. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00048-2 · Cited by 10
Diabetes Surveillance in Germany – Background, concept and prospects
Koch-Institut, R. (2017) · PubMed Central · doi:10.17886/rki-gbe-2017-022 · Cited by 14
“Furthermore, appropriate preventive measures have also reduced the proportion of diabetes-related eye diseases and the rate of new occurrences of kidney disease [9, 39, 40].”
BackgroundYokoyama, H., Araki, S., Kawai, K., Hirao, K., Kurihara, Y., Seino, H., Takamura, H., Sugimoto, H., Okada, A., & Maegawa, H. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12714 · Cited by 7
Sone, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99593-0 · Cited by 10
Kerola, A. M., Juonala, M., & Kytö, V. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112411 · Cited by 6
Sachmechi, I., Salam, S., Amini, M., Khan, R., Spitznogle, A., & Belen, T. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.03.270 · Cited by 9
Piniés, J. A., González-Carril, F., & Arteagoitia, J. M. (2015) · Avances en Diabetología · doi:10.1016/j.avdiab.2015.02.001 · Cited by 14
Variation in Diabetes Management: A National Assessment of Primary Care Providers
Peabody, J. W., de Belen, E., Dahlen, J. R., Acelajado, M. C., Tran, M. T., & Paculdo, D. R. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819861662 · Cited by 6
“In a recent study, more than 20% of patients with diabetes do not meet their HbA1c targets of <8%, and nearly half do not meet their HbA1c targets of <7%.(9) Many patients with diabetes (such as postprandial hyperglycemia, patients on medications, or ones with other comorbidities) have even more complex needs.”
BackgroundOrsi, E., Bonora, E., Solini, A., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Zerbini, G., Morano, S., Nicolucci, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010246 · Cited by 6
“%) and much higher than that of patients meeting the more stringent HbA1c goal of <6.5% (23.3%), consistent with previous reports from the National Health and Nutrition Examination Survey (NHANES) [27,28].”
ResultInfluentialCalderón-Ticona, J. R., Taype-Rondán, Á., Villamonte, G., Labán-Seminario, L. M., Helguero-Santin, L. M., Miranda, J. J., & Lazo‐Porras, M. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.014 · Cited by 6
Giorda, C. B., Rossi, A., Baccetti, F., Zilich, R., Romeo, F., Nreu, B., Cianni, G. D., Guaita, G., Morviducci, L., Muselli, M., et al. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.06.006 · Cited by 6
Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes
Williams, B. A., RAJPURA, J. R., Paprocki, Y., Kumar, N., Voyce, S. J., Brady, J. P., & Chang, A. R. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.07.012 · Cited by 7
Abdel‐Rahman, N., Manor, O., Cohen, A. D., Elran, E., Golan‐Cohen, A., Krieger, M., Paltiel, O., Valinsky, L. J., Ben‐Yehuda, A., & Calderon‐Margalit, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302422 · Cited by 6
Shah, B. R., Hwee, J., Anand, S. S., Austin, P. C., Manuel, D. G., & Hux, J. E. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.02.002 · Cited by 7
Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery
Khanna, V., & Kashyap, S. R. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0537-2 · Cited by 7
Wong, C. K. H., Fung, C. S. C., Yu, E. Y. T., Wan, E. Y. F., Chan, A. K. C., & Lam, C. L. K. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2952 · Cited by 6
“Many developed countries have implemented quality improvement initiatives to successfully improve the quality of diabetes care[7-14].”
BackgroundHbA 1c Outcomes in Patients Treated With Canagliflozin Versus Sitagliptin in US Health Plans
Thayer, S., Aguilar, R. B., Korrer, S., & Chow, W. S. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.08.019 · Cited by 6
Aron, D. C., Tseng, C., Soroka, O., & POGACH, L. M. (2018) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzy151 · Cited by 7
“analyzed data from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System in adults with selfreported diabetes [36].”
MethodType 2 diabetes: Prescription patterns and treatment outcomes of IDMPS survey in Argentina
José, G. J., Elgart, J. F., Forti, L., Querzoli, I., & CHANTELOT, J.-M. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.008 · Cited by 7
Philis‐Tsimikas, A., Lane, W. S., Pedersen‐Bjergaard, U., Wysham, C., Bardtrum, L., Østoft, S. H., & Heller, S. R. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13954 · Cited by 7
“0% (53 mmol/mol).(28) Our findings suggest that treatment with degludec might help to alleviate a limitation to glycaemic control—hypoglycaemia—and thus might facilitate improved glycaemic control in patients with diabetes when compared with glargine U100 treatment.”
BackgroundLarry, M., Alizadeh, S., Naderi, S., Salekani, B., Mansournia, M. A., Rabizadeh, S., Esteghamati, A., & Nakhjavani, M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.015 · Cited by 6
Evolving Concepts of Type 2 Diabetes Management
Abushamat, L. A., & Reusch, J. E. B. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.003 · Cited by 7
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
Minze, M. G., & Chastain, L. M. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s73579 · Cited by 6
“Despite concerted efforts and guidance, up to 49% of patients do not meet their hemoglobin A1c (HbA1c), blood pressure, or lipid goal.(5) Initial combination therapy is recommended for patients with higher HbA1c levels at baseline (ie, $9%) who are unlikely to gain control with monotherapy.”
BackgroundBrunton, S., Rozjabek, H., Pilon, D., Lafeuille, M., Kamstra, R. L., Wynant, W., Bookhart, B., & Lefèbvre, P. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1605160 · Cited by 6
Odoi, E. W., Nagle, N. N., DuClos, C., & Kintziger, K. W. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234734 · Cited by 7
Xi, Y., Bao, H., Han, K., Qiao, L., Xu, X., Zhu, H., Yan, T., Niu, L., Hang, G., Wang, W., et al. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106174 · Cited by 6
Qin, Y., Adams, J. M., Solis‐Herrera, C., Triplitt, C. L., DeFronzo, R. A., & Cersósimo, E. (2020) · Diabetes Care · doi:10.2337/dc19-1993 · Cited by 7
“0% (53 mmol/mol) for glycemic control (3).”
Coughlin, S. S., Heboyan, V., Young, L., Leo, G. D., & Wilkins, T. (2018) · Journal of Hospital Management and Health Policy · doi:10.21037/jhmhp.2018.04.04 · Cited by 6
New guidelines for metabolic targets in diabetes: clinician’s opinion does matter
Esposito, K., Maiorino, M. I., Bellastella, G., & Giugliano, D. (2014) · Endocrine · doi:10.1007/s12020-014-0205-2 · Cited by 6
“The data from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System over the 1999–2010 period show that 52 % of survey participants (adults with self-reported diabetes) achieved the hemoglobin A1c (HbA1c) target \7 % from 2007 through 2010 [6].”
MethodAbdul‐Ghani, M. A., & DeFronzo, R. A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.15 · Cited by 7
Fujita, N., Yamamoto, Y., Hayashino, Y., Kuwata, H., Okamura, S., Iburi, T., Furuya, M., Kitatani, M., Yamazaki, S., Ishii, H., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12693 · Cited by 7
Kozela, M., Matras, A., Koziara, K., Małecki, M. T., & Pająk, A. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s403521 · Cited by 5
Usman, N. U. B., Winson, T., Roy, P. B., Tejani, V. N., Dhillon, S. S., Damarlapally, N., & Panjiyar, B. K. (2023) · Cureus · doi:10.7759/cureus.47294 · Cited by 7
“Only 40%-60% of diabetic individuals achieve LDL-C values below 100 mg/dL [26,27].”
Background
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.